Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Heart and Vessels
Metadata
Title
Acrobatic vascular disease
Authors
Jerzy Wojciuk
Roger W. Bury
Michael J. Brack
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Heart and Vessels / Issue 3/2006
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-005-0878-9

Other articles of this Issue 3/2006

Heart and Vessels 3/2006 Go to the issue

ORIGINAL ARTICLE

Safety of gadodiamide mixed with a small quantity of iohexol in patients with impaired renal function undergoing coronary angiography

CASE REPORT

Left ventricular aneurysm associated with isolated noncompaction of the ventricular myocardium

CASE REPORT

A permanent junctional reciprocating tachycardia with an atypically located accessory pathway successfully ablated from within the middle cardiac vein

CASE REPORT

Noncompaction of the ventricular myocardium combined with polycystic kidney disease

ORIGINAL ARTICLE

Is the coronary flow velocity reserve improvement after aortic valve replacement for aortic stenosis transient? Results of a 3-year follow-up

ORIGINAL ARTICLE

Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits